INJ: Stronger Infrastructure, Weaker Price
Injective keeps expanding its infrastructure, but INJ still trades near $8.60—about 67% below its 2025 high.
EVM expansion, institutional validators, and a U.S. staked-INJ ETF filing add to the story. But announcements aren’t adoption. Sustained trading activity, RWA growth, and measurable token demand still need to prove themselves.
This is a watch, not a long.
$7.00 is the key support. Reclaiming $9.38 would be the first sign of improving momentum. Until usage and capital inflows strengthen, the thesis remains unproven.
